Reaction profile

The FDA adverse-event record for pr-pleural effusion

Name: PR-PLEURAL EFFUSION - FDA Animal Adverse Reaction
Creator: PlainBreed
License: https://open.fda.gov/license/

36 FDA reports name pr-pleural effusion, a lower-volume reaction in the CVM extract (VeDDRA 99668). Plate stamps and neighbourhood peers follow.

#1913 of 2,481
by report volume (all reactions): 36
reports citing this reaction: 83.3%
death-coded share: Cat
most-affected species

Compiled by PlainBreed

Verify with FDA CVM →

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. PR-PLEURAL EFFUSION has 36 reports now versus 36 in that prior snapshot: 0 the same number of (0.0%).

Report change: +0
Death-coded reports: +0
Death-coded share: +0.0 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to PR-PLEURAL EFFUSION changes

FDA AER · VeDDRA plate

Code 99668 VOL-TRACE

VOL-TRACE · DEATH-HOT · LOWER-Q · PHOTO-FINISH · SPECIES-CAT · DRUG-LEAD · DESK-WIDE · BOOK-FULL

VOL-TRACE 36 reports
DEATH-HOT 83.3%
LOWER-Q #1913/2481
PHOTO-FINISH Abnormal birth weight
SPECIES-CAT Cat · 20
DRUG-LEAD Cefovecin Sodium · 7
DESK-WIDE 19 breeds
BOOK-FULL 8/8 fields

Nearest volume peer: Abnormal birth weight (±0 reports)

Upper-third death-coded share drives the outcome stamps on this plate; volume band, corpus rank, and co-report peers follow. Not a clinical diagnosis.

Lower-volume neighbourhood around PR-PLEURAL EFFUSION

Lower-third volume poles plus nearest peers, not a full reaction corpus board reprint.

FDA AER report volume · neighbourhood around PR-PLEURAL EFFUSION

PR-PLEURAL EFFUSION: high death-coded share in the FDA AER plate

Signature read: PR-PLEURAL EFFUSION's 83.3% death-coded share is among the highest in the openFDA reaction corpus. Report volume is lower-third scale: 36 named reports in the openFDA extract. Death-coded share is upper-third: 30 of 36 reports (83.3% of named reports). Nearest volume peer: Abnormal birth weight (±0 reports). Lead species Cat (20). Lead co-reported drug Cefovecin Sodium (7).

Read these counts as reporting volume, not risk: per our methodology, A high death-coded share in FDA filings does not prove causation; co-reporting is voluntary temporal association only. Browse the full reactions index or the about page for how PlainBreed frames FDA CVM extracts.

Species Most Affected

Cat 20

Dog 14

Horse 2

Breeds Most Affected

Domestic (unspecified) 11

Domestic Shorthair 5

Crossbred Canine/dog 2

Domestic Longhair 2

Shepherd Dog - Australian 2

Mastiff 1

Siamese 1

Dachshund (unspecified) 1

Shih Tzu 1

Cat (unknown) 1

Associated Drugs

Cefovecin Sodium 7

Cefovecin 7

Dexamethasone 3

Enrofloxacin 3

Oclacitinib Maleate 3

Dexmedetomidine Hydrochloride 2

Meloxicam 2

Carprofen 2

Imidacloprid + Moxidectin 2

Butorphanol 2

Furosemide 2

Methylprednisolone Acetate 2

Selamectin 2

Deracoxib 1

Spinosad 1

Tiletamine, Zolazepam 1

Lufenuron 1

Atipamezole 1

Vitamin A 1

Vitamin D 1

What to do with this reaction

Read how death-coded share differs from a mortality rate before drawing conclusions. Understanding adverse events
Browse the full reaction directory to compare report counts across reaction types. All reactions

A report does not prove a drug caused the reaction; consult a veterinarian before acting on this data.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for PR-PLEURAL EFFUSION (#1913 of 2,481 by report volume); death-coded 83.3%. PlainBreed reaction plate · death-coded share stamp 83.3% · vintage 2025.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →